Through the Eyes of a Giant

A new play explores the mind of the father of modern physics through his interactions—factual and imagined—with a curmudgeonly colleague.

Written byMary Beth Aberlin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Eduardo Paolozzi's Newton, in the courtyard of the British Library in LondonWIKIMEDIA, SOLIPSISTRenowned microscopist Robert Hooke haughtily asks Isaac Newton if he’d ever had a play written about him when the two first meet in Lucas Hnath's new play Isaac's Eye. Set sometime during the plague year 1665–66, this meeting never actually happened, which is the case with a number of scenes in the play. Isaac’s Eye opens with a twentysomething Newton, confident of his genius, explaining his obsession with gaining entry into the Royal Society (founded in November 1660) of which Hooke was the Curator of Experiments. The young physicist is intent on explaining a cornucopia of his ideas to the most learned men in England. He wants to pierce them with his intelligence. After several rebuffs, Newton has forced the meeting by sending Hooke all of his work, leaving the curator worried about being scooped by Newton's findings on the nature of light.

What follows is a thoroughly engaging, thought-provoking, and often very funny exchange of ideas between two titans of science. Hnath plays Newton's decidedly odd, tortured personality off of the prickly Hooke, who was just 7 years Newton’s elder, but definitely more a man in and of the world. The two argue about things that still obsess practitioners of science to this day: experimental design, researcher bias, the importance of replicability, the value of thought experiments, credit for discovery—and they dis each other in earthy 21st-century language.

Throughout the play a narrator separates fact from fiction. True: Hooke was satirized in plays. False: This had already happened when he meets Newton in the play. True: the men were bitter scientific rivals. True: they both were interested ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies